Published in BMJ on March 16, 1991
The place of computed tomography and lumbar puncture in suspected bacterial meningitis. Arch Dis Child (1992) 1.95
Bacterial meningitis in Swaziland: an 18 month prospective study of its impact. J Epidemiol Community Health (1994) 0.95
Paediatrics--Part II. Postgrad Med J (1993) 0.84
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet (1987) 7.24
Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med (1988) 4.17
Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J (1989) 2.37
Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet (1980) 2.15
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med (1984) 1.69
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest (1989) 1.48
Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis (1988) 1.29
Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. Am J Dis Child (1989) 1.27
Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis (1989) 1.18
Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis (1989) 1.15
Management of bacterial meningitis in infants and children. Current status and future prospects. Am J Med (1984) 1.07
Dexamethasone in bacterial meningitis: increasing evidence for a beneficial effect. Pediatr Infect Dis J (1989) 1.05
Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr Infect Dis J (1989) 0.93
Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases. Pediatr Infect Dis J (1989) 0.91
Prostaglandins E2 and I2, interleukin 1-beta, and tumor necrosis factor in cerebrospinal fluid in infants and children with bacterial meningitis. Pediatr Infect Dis J (1989) 0.85
Cerebral blood flow and metabolism in experimental meningitis. Pediatr Infect Dis J (1989) 0.83
Bacterial meningitis. Rational selection and use of antibacterial drugs. Drugs (1986) 0.82
Role of endogenous excitatory amino acid neurotransmitters in the pathogenesis and evolution of acute brain injury. Pediatr Infect Dis J (1989) 0.79
Modulation of meningeal inflammation by treatment with pentoxifylline. Pediatr Infect Dis J (1989) 0.79
Pathophysiology of bacterial meningitis: summary of the workshop. Pediatr Infect Dis J (1989) 0.78
Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis. Eur J Clin Microbiol Infect Dis (1989) 0.77
Prospective study of the aetiology and outcome of pneumonia in the community. Lancet (1987) 4.53
Hospital study of adult community-acquired pneumonia. Lancet (1982) 4.52
Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (1999) 2.23
Group B streptococci in the female genital tract. Br Med J (1976) 2.04
Serological grouping of streptococci by a slide coagglutination method. J Clin Pathol (1977) 1.88
Sales of over-the-counter remedies as an early warning system for winter bed crises. Clin Microbiol Infect (2003) 1.58
Prophylaxis after splenectomy. J Antimicrob Chemother (1994) 1.46
Fever of unknown origin. Clin Med (2001) 1.40
Ciprofloxacin and CAPD peritonitis. J Antimicrob Chemother (1990) 1.40
T-cell lymphoma associated with human immunodeficiency virus (HIV) infection. Histopathology (1990) 1.39
Infective endocarditis after transesophageal echocardiography. Circulation (1993) 1.39
A hospital study of community acquired pneumonia in the elderly. Thorax (1990) 1.32
Characterization of cell envelope proteins of Staphylococcus epidermidis cultured in human peritoneal dialysate. Infect Immun (1991) 1.25
Hepatitis C virus infection. Clin Microbiol Infect (2005) 1.19
Time for action on hepatitis B immunisation. Br Med J (Clin Res Ed) (1987) 1.17
Medical decompression of vertebral hydatidosis. Spine (Phila Pa 1976) (1997) 1.16
Variation in the expression of cell envelope proteins of coagulase-negative staphylococci cultured under iron-restricted conditions in human peritoneal dialysate. J Gen Microbiol (1991) 1.09
Streptobacillus moniliformis isolated from blood in four cases of Haverhill fever. Lancet (1983) 1.08
Experimental infection of human nasal mucosal explants with Neisseria meningitidis. J Med Microbiol (1995) 1.06
Influence of carbon dioxide on growth and antibiotic susceptibility of coagulase-negative staphylococci cultured in human peritoneal dialysate. J Clin Microbiol (1990) 1.06
Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber. J Antimicrob Chemother (1991) 1.05
A case of herpes zoster associated encephalitis with rapid response to acyclovir. Postgrad Med J (1985) 1.04
Characterisation and antibiotic susceptibilities of Streptobacillus moniliformis. J Med Microbiol (1986) 1.04
Influence of carbon dioxide on the surface characteristics and adherence potential of coagulase-negative staphylococci. J Clin Microbiol (1990) 1.03
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med (1996) 1.02
Streptococcus MG-intermedius (Streptococcus milleri) septic arthritis in a patient with rheumatoid arthritis. J Rheumatol (1980) 1.02
A clinico-pathological study of diabetic foot ulcers. Diabet Med (1987) 1.00
Immunomodulating activity of rifampicin. J Chemother (2004) 0.98
A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis (1986) 0.97
Risks from cannulae used to maintain intravenous access. Br Med J (1980) 0.97
Unsuspected tuberculosis in general hospitals. Lancet (1973) 0.97
A comparison of mucosal inflammatory responses to Giardia muris in resistant B10 and susceptible BALB/c mice. Parasite Immunol (1997) 0.96
Comparison of antibody and cytokine responses to primary Giardia muris infection in H-2 congenic strains of mice. Infect Immun (1996) 0.94
A novel method for collecting and detecting amoxycillin in urine: a tool for testing antibiotic compliance in the community. J Antimicrob Chemother (2000) 0.93
Relapse of pseudomembranous colitis after vancomycin therapy. Lancet (1979) 0.93
The management of splenic abscess. Q J Med (1985) 0.91
Group G streptococcal septicaemia: clinical observations and laboratory studies. J Infect (1984) 0.90
The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline. J Antimicrob Chemother (1988) 0.88
The treatment of paediatric infections with the lincomycins. Br J Clin Pract (1973) 0.88
Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med (1997) 0.87
Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect (1998) 0.87
Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group. J Antimicrob Chemother (1993) 0.86
Ludwig's angina. JAMA (1980) 0.86
Uncommon Haemophilus infections. Br Med J (Clin Res Ed) (1984) 0.86
Laboratory studies on coagulase-negative staphylococci from CAPD-associated peritonitis. J Antimicrob Chemother (1985) 0.86
Meningococcal chemoprophylaxis. Br Med J (Clin Res Ed) (1981) 0.84
Long-term management after splenectomy. ... and may be ineffective. BMJ (1994) 0.82
Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant (1994) 0.82
Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clin Microbiol Infect (2001) 0.81
Pseudomonas peritonitis in continuous ambulatory peritoneal dialysis: laboratory predictors of treatment failure. J Hosp Infect (1987) 0.81
Vidarabine in fulminating chickenpox pneumonia. Thorax (1982) 0.81
Community-acquired pneumonia. J Hosp Infect (1992) 0.80
Erythromycin compared with a combination of ampicillin and amoxycillin as initial therapy for adults with pneumonia including Legionnaires' disease. J Infect (1983) 0.80
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. J Antimicrob Chemother (1996) 0.80
Reducing risks from intravenous cannulae. Br Med J (Clin Res Ed) (1981) 0.79
A morphological study of bacterial colonisation of intravenous cannulae. J Med Microbiol (1985) 0.78
Sporicides for Clostridium difficile: the devil is in the detail. J Hosp Infect (2011) 0.78
Antibiotic susceptibility of staphylococci from CAPD peritonitis in children. J Antimicrob Chemother (1987) 0.78
Evaluation of the end-expiratory pressure by multiple linear regression and Fourier analysis in humans. Respir Med (2002) 0.78
Pharmacokinetic studies of imipenem/cilastatin in elderly patients. J Antimicrob Chemother (1986) 0.77
MHC haplotype influences primary Giardia muris infections in H-2 congenic strains of mice. Int J Parasitol (1993) 0.77
Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. J Infect (1996) 0.77
Nosocomial lower respiratory tract infections in surgical wards. Thorax (1990) 0.77
Pneumocystis carinii pneumonia. Thorax (1985) 0.77
The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults. Thorax (2000) 0.76
Entamoeba histolytica infection in male homosexuals. Gut (1980) 0.76
In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Chemioterapia (1987) 0.76
Over the counter drugs. Working party will see whether antimicrobials should be available. BMJ (1996) 0.75
Oropharyngeal production of pneumococcal capsular antigen and the potential for contamination of expectorated sputum samples in pneumococcal pneumonia. Epidemiol Infect (1993) 0.75
Diagnostic and management problems in a complex case of connective tissue disease. Postgrad Med J (1995) 0.75
Pittsburgh pneumonia agent and legionellosis in Nottingham. Br Med J (Clin Res Ed) (1981) 0.75
Syringes for diabetics. Br Med J (Clin Res Ed) (1985) 0.75
The complications of intravenous cannulae incorporating a valved injection side port. J Hyg (Lond) (1984) 0.75
HCV infection in blood donors. Br J Hosp Med (1995) 0.75
Stimulation of growth on a deficient medium of a Klebsiella aerogenes species by sulphonamide, para-amino benzoic acid, nitrofurantoin, and some other substances. J Clin Pathol (1972) 0.75
Legionnaires' disease. W V Med J (1978) 0.75
Serious group A streptococcal infections complicating cryotherapy to lip haemangiomas. Clin Exp Dermatol (1993) 0.75
A clinical, microbiological and toxicological assessment of clindamycin phosphate. J Antimicrob Chemother (1975) 0.75
Prolonged high-dose administration of sodium nitroprusside in the intensive care unit. Intensive Care Med (1998) 0.75
Bacterial resistance to trimethoprim in geriatric medical wards. Gerontology (1989) 0.75
Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection. J Antimicrob Chemother (1991) 0.75
Studies on the microbiological safety of the valved side-port of the 'Venflon' cannula. J Hosp Infect (1985) 0.75
Antibiotic resistance. Br J Hosp Med (1997) 0.75
In-vitro antimicrobial susceptibility testing: does it really matter? J Chemother (1997) 0.75
The effect of an antibiotic policy on bacterial resistance in patients in geriatric medical wards. Q J Med (1986) 0.75
Patient education and communication in non-inpatient intravenous therapy--a review. Eur J Haematol Suppl (1998) 0.75
Penicillin-resistant pneumococci. Lancet (1995) 0.75
The use of injectable antibiotics in two general hospitals. J Antimicrob Chemother (1984) 0.75
Hepatitis B protection of endoscopy staff. Lancet (1986) 0.75
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis. J Antimicrob Chemother (1987) 0.75
Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet (1986) 0.75
Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983-1988. J Med Microbiol (1991) 0.75
[Antibiotic resistance for the year 2000]. Enferm Infecc Microbiol Clin (2001) 0.75
Treatment of Lancefield group B streptococcal infections. J Antimicrob Chemother (1978) 0.75
Meningococcal infections: sixteen years' experience. W V Med J (1978) 0.75